StemCells, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Business Update

Go back to StemCells, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Business Update

Stemcells (STEM) Reports In-Line Q4 Loss of 13c/Share

March 12, 2014 3:31 PM EDT

Stemcells (NASDAQ: STEM) reported Q4 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $312 thousand versus the consensus estimate of $220 thousand.

For earnings history and earnings-related data on Stemcells (STEM) click here.... More